Moreover, celastrol was also found to be a potent Aβ lowering compound by reducing the β-cleavage of APP (Amyloid precursor protein) in a transgenic mouse model of Alzheimer’s disease [12,13]. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.